Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2009 2
2010 2
2011 2
2012 4
2013 3
2014 7
2015 13
2016 10
2017 19
2018 25
2019 24
2020 15
2021 23
2022 14
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30877180

133 results

Results by year

Filters applied: . Clear all
Page 1
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD Sr, Joshi AD, Navitsky M, Southekal S, Pontecorvo MJ, Shen H, Lu M, Shankle WR, Seibyl JP, Marek K, Mintun MA. Devous MD Sr, et al. J Nucl Med. 2018 Jun;59(6):937-943. doi: 10.2967/jnumed.117.200691. Epub 2017 Dec 28. J Nucl Med. 2018. PMID: 29284675 Free article.
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M, Verwer EE, Meltzer AC, Kim SJW, Agüero C, Gonzalez J, Makaretz SJ, Siao Tick Chong M, Ramanan P, Amaral AC, Normandin MD, Vanderburg CR, Gomperts SN, Johnson KA, Frosch MP, Gómez-Isla T. Marquié M, et al. Acta Neuropathol Commun. 2017 Oct 19;5(1):75. doi: 10.1186/s40478-017-0482-0. Acta Neuropathol Commun. 2017. PMID: 29047416 Free PMC article.
18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD. Schonhaut DR, et al. Ann Neurol. 2017 Oct;82(4):622-634. doi: 10.1002/ana.25060. Ann Neurol. 2017. PMID: 28980714 Free PMC article.
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM, Wiste HJ, Senjem ML, Gunter JL, Weigand SD, Schwarz CG, Arani A, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Kantarci K, Vemuri P, Boeve BF, Mielke MM, Petersen RC, Jack CR Jr. Cogswell PM, et al. Neuroimage. 2021 Jan 1;224:117433. doi: 10.1016/j.neuroimage.2020.117433. Epub 2020 Oct 6. Neuroimage. 2021. PMID: 33035667 Free PMC article.
Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships.
Wolters EE, Ossenkoppele R, Golla SS, Verfaillie SC, Timmers T, Visser D, Tuncel H, Coomans EM, Windhorst AD, Scheltens P, van der Flier WM, Boellaard R, van Berckel BN. Wolters EE, et al. Neuroimage Clin. 2020;25:102113. doi: 10.1016/j.nicl.2019.102113. Epub 2019 Dec 2. Neuroimage Clin. 2020. PMID: 31835238 Free PMC article.
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, Seeley WW, Ramos EM, Coppola G, Gorno-Tempini ML, Miller BL, Rosen HJ, Jagust W, Boxer AL, Rabinovici GD. Tsai RM, et al. Alzheimers Res Ther. 2019 Jan 31;11(1):13. doi: 10.1186/s13195-019-0470-7. Alzheimers Res Ther. 2019. PMID: 30704514 Free PMC article.
133 results